Form D · Biotechnology
Lyndra Therapeutics, Inc.
Watertown, MA · CIK 0001679037
Offering snapshot reported Dec 29, 2023 · SEC filing
- Reported sold
- $123M Offering amount: $206M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 15, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2023 | Initial | $122,749,667 | No comparison | 16 | SEC filing |
| Jun 7, 2023 | Initial | $20,350,715 | No comparison | 7 | SEC filing |
| Jun 23, 2021 | Initial | $60,470,112 | No comparison | Not reported | SEC filing |
| Jan 28, 2019 | Initial | $55,243,392 | No comparison | 23 | SEC filing |
| Apr 19, 2017 | Amendment | $23,082,575 | $3,000,000vs Mar 7, 2017 | 15 | SEC filing |
| Mar 7, 2017 | Amendment | $20,082,575 | $2,999,999vs Feb 10, 2017 | 15 | SEC filing |
| Feb 10, 2017 | Amendment | $17,082,576 | $11,149,992vs Jul 13, 2016 | 14 | SEC filing |
| Jul 13, 2016 | Initial | $5,932,584 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-501189
Source: Form D, filed Dec 29, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zafi S. Avnur | Director |
| Jessica Ballinger | Director, Executive |
| Andrew M. Bellinger | Executive |
| Doug Dachille | Director |
| Edmund P. Harrigan | Director |
| Patricia Hurter | Director |
| Robert S. Langer | Director |
| Helene Madonick | Director |
| Jillian Moo Young | Director |
| Catherine Reynolds | Director |
| Amy Schulman | Director |
| Ashish Singh | Director |
| Carlo Giovanni Traverso | Director |
| Carlo Giovanni Traverso | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
65 Grove Street, Suite 301
Watertown, MA, 02472
Watertown, MA, 02472